QRG Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

QRG Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.3M	Buy	368,848 +12,952	+4%	+$744K	0.18%	104
2026 Q1	$21.6M	Buy	355,896 +64,689	+22%	+$3.77M	0.22%	95
2025 Q4	$15.7M	Buy	291,207 +21,399	+8%	+$1.03M	0.17%	116
2025 Q3	$12.2M	Sell	269,808 -75,294	-22%	-$3.52M	0.15%	133
2025 Q2	$16M	Sell	345,102 -8,440	-2%	-$414K	0.14%	151
2025 Q1	$21.6M	Buy	353,542 +43,977	+14%	+$2.56M	0.22%	96
2024 Q4	$17.5M	Buy	309,565 +20,177	+7%	+$1.13M	0.18%	118
2024 Q3	$15M	Sell	289,388 -12,074	-4%	-$566K	0.16%	131
2024 Q2	$12.5M	Sell	301,462 -242,270	-45%	-$10.8M	0.15%	143
2024 Q1	$29.5M	Buy	543,732 +72,390	+15%	+$3.69M	0.37%	58
2023 Q4	$24.2M	Sell	471,342 -52,424	-10%	-$2.75M	0.36%	59
2023 Q3	$30.4M	Buy	+523,766	New	+$32.1M	0.53%	35

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

QRG Capital Management's BMY Position: Q2 2026 in Review

QRG Capital Management increased its Bristol-Myers Squibb (BMY) stake by 3.6% in Q2 2026, buying an estimated $744K and bringing the position to 368,848 shares worth $21.3M. The position accounts for 0.18% of the portfolio, ranked #104.

QRG Capital Management first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $30.4M in Q3 2023. 964 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

QRG Capital Management held 368,848 shares of Bristol-Myers Squibb worth $21.3M as of Q2 2026.
QRG Capital Management bought 12,952 Bristol-Myers Squibb shares in Q2 2026, an estimated $744K.
Bristol-Myers Squibb made up 0.18% of QRG Capital Management's portfolio in Q2 2026, its #104 holding.
QRG Capital Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
QRG Capital Management's Bristol-Myers Squibb position peaked at $30.4M in Q3 2023.
964 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.